Germany vs Italy: The number of people with susceptibility test result for rifampicin
Germany
1,440
in 2021
Italy
1,391
in 2021
Germany rank
58th
Italy rank
60th
The number of people with susceptibility test result for rifampicin over time
- Germany
- Italy
How they compare
Germany currently reports 1,440 against 1,391 in Italy, a difference of 49.
The two have swapped places 1 time across 5 shared years of data; in 2017 it was Italy ahead.
Germany ranks 58th and Italy ranks 60th of 155 countries.
Across the 2 decades both report, Germany averaged higher in 1 and Italy in 1.
Head to head by decade
| Decade | Germany | Italy | Difference | Ahead |
|---|---|---|---|---|
| 2010s | 1,298 | 1,785 | 487 | Italy |
| 2020s | 1,502 | 1,278 | 224.5 | Germany |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher the number of people with susceptibility test result for rifampicin, Germany or Italy?
- Germany, at 1,440 against 1,391 in Italy as of 2021.
- What is the difference in the number of people with susceptibility test result for rifampicin between Germany and Italy?
- 49, with Germany ahead.
- How many years of comparable data are there for Germany and Italy?
- 5 years are reported by both, from 2017 to 2021.
- How do Germany and Italy rank globally for the number of people with susceptibility test result for rifampicin?
- Germany ranks 58th and Italy ranks 60th of 155 countries.
- Where does this data come from?
- World Health Organization, Global Health Observatory, published as The number of people with susceptibility test result for rifampicin among bacteriologically confirmed pulmonary TB patients.. Statizoid refreshes it automatically from the source and publishes the full history for both places.